Healthcare Drinks is supporting the online event below:
3E Biovetures invited the two co-founders of OncoImmune, a Chinese -born immunologist Prof. Liu Yang and Dr. Zheng Pan, who have launched the phase III trial for critical COVID-19 patient, to share with everyone how to intervene in the inflammatory storm of COVID-19.
